Moolec Science SA - Ordinary Shares (NQ:MLEC)

0.4096 -0.0094 (-2.24%)

Streaming Delayed Price Updated: 3:59 PM EST, Nov 26, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Moolec Science SA - Ordinary Shares

< Previous 1 2 3 4 Next >

US Stocks Open Higher; Dow Rises 150 Points ↗

January 09, 2023

U.S. stocks traded higher this morning, with the Dow Jones gaining around 150 points on Monday.

Via Benzinga

Why CinCor Pharma Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket ↗

January 09, 2023

Gainers CinCor Pharma, Inc. (NASDAQ: CINC) rose 140.2% to $28.30 in pre-market trading after AstraZeneca announced plans to buy the company for up to $1.8 billion.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

January 09, 2023

We're starting off the week with a look at the biggest pre-market stock movers traders need to know about on Monday morning!

Via InvestorPlace

Macy's, DoorDash And Some Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

January 09, 2023

U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. Moolec Science SA (NASDAQ: MLEC) shares dropped 28.4% to $13.78 in...

Via Benzinga

Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

January 06, 2023

Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

January 05, 2023

We're starting off the day with a breakdown of the biggest pre-market stock movers for Thursday that traders need to know about!

Via InvestorPlace

Why Enovix Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 04, 2023

Gainers Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares surged 204% to $2.25 after the company announced it received FDA 510(k) clearance for its DNA oral appliance for the treatment of obstructive...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.